High level of anti-drug antibodies after intra-articular injection of anti-TNF

被引：1
|
作者：
Zufferey, Pascal [1 ]
Perreau, Mathieu [2 ]
So, Alexander [1 ]
机构：
[1] CHU Vaudois, Dept Appareil Locomoteur, Serv Rhumatol, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Serv Immunol, CH-1011 Lausanne, Switzerland
来源：
RHEUMATOLOGY | 2015年 / 54卷 / 12期
关键词：
PERSPECTIVE;
D O I：
10.1093/rheumatology/kev325
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2291 / 2292
页数：2
相关论文
共 50 条
  • [1] High level of antibodies against anti-TNF agents after intra-articular injections for a nonspecific monoarthritis of the knee
    Zufferey, P.
    Andrei, I.
    Perreau, M.
    So, A.
    SWISS MEDICAL WEEKLY, 2014, 144 : 6S - 6S
  • [2] INCREASED RISK OF ANTI-DRUG ANTIBODIES TO A SECOND ANTI-TNF IN PATIENTS WHO DEVELOPED ANTIBODIES TO THE FIRST ANTI-TNF
    Yanai, Henit A.
    Amir, Shira
    Avni-Biron, Irit
    Perets, Tsachi Tsadok
    Shamir, Raanan
    Dotan, Iris
    Assa, Amit
    GASTROENTEROLOGY, 2020, 158 (06) : S671 - S671
  • [3] Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF
    Yanai, H.
    Amir, S.
    Biron, I. Avni
    Perets, T. Tsadok
    Shamir, R.
    Dotan, I.
    Assa, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S439 - S439
  • [4] LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF
    Cheifetz, Adam S.
    Abreu, Maria T.
    Flier, Sarah N.
    Papamichail, Konstantinos
    Rieder, Florian
    Silverberg, Mark S.
    Khanna, Reena
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Vande Casteele, Niels
    GASTROENTEROLOGY, 2020, 158 (06) : S457 - S457
  • [5] ANTI-DRUG ANTIBODIES AS A PREDICTOR FOR THE DISCONTINUATION OF ANTI-TNF AGENTS IN PATIENTS WITH SPONDYLOARTHRTIS
    Kim, H. J.
    Hwang, J.
    Kim, I.
    Jeong, H.
    Lee, J.
    Jeon, C. H.
    Koh, E. -M.
    Cha, H. -S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 717 - 718
  • [6] ANTI-DRUG ANTIBODIES: ASSAY PERFORMANCE IN PATIENTS TREATED WITH ANTI-TNF BIODRUGS
    Hock, B.
    O'donnell, J. L.
    Liu, J.
    Keating, P.
    Spellerberg, M.
    Stamp, L.
    Barclay, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1415 - 1415
  • [7] ANTI-DRUG ANTIBODIES, DRUG LEVELS AND CLINICAL EFFICACY OF THE ANTI-TNF BIOLOGICS IN RHEUMATIC DISEASES
    Mok, C. C.
    van der Kleij, D.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 226 - 226
  • [8] Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases
    C. C. Mok
    D. van der Kleij
    G. J. Wolbink
    Clinical Rheumatology, 2013, 32 : 1429 - 1435
  • [9] Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases
    Mok, C. C.
    van der Kleij, D.
    Wolbink, G. J.
    CLINICAL RHEUMATOLOGY, 2013, 32 (10) : 1429 - 1435
  • [10] Relevance of anti-drug antibodies in context of supra-therapeutic anti-TNF concentrations
    Kim, J.
    Walshe, M.
    Borowski, K.
    Milgrom, R.
    Stempak, J.
    Lee, S. H.
    Croitoru, K.
    Silverberg, M. S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I933 - I934
12345